GLOW vs PT-141
GLOW and PT-141 are both studied in skin research, but they are different classes of compound with different reported research applications.
✓ both US-made · third-party tested · batch COA on every order
Last updated August 25, 2026
How do GLOW and PT-141 differ?
GLOW (Co-formulated three-peptide research blend) is catalogued under skin & glow research; PT-141 (Synthetic cyclic heptapeptide melanocortin agonist) is catalogued under skin & glow research. Verve lists 5 reported research applications for GLOW and 5 for PT-141. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.
| field | GLOW | PT-141 |
|---|---|---|
| compound class | Co-formulated three-peptide research blend | Synthetic cyclic heptapeptide melanocortin agonist |
| research area | skin & glow | skin & glow |
| reported research applications | 5 listed | 5 listed |
| supplied as | co-formulated blend | single compound |
| catalog sizes | 70mg | 10mg |
| purity standard | 99%+ by HPLC | 99%+ by HPLC |
| manufactured | United States | United States |
| batch COA | published per lot | published per lot |
| endotoxin-tested option | available | not offered |
| co-formulated together in | not co-formulated | not co-formulated |
| price from | $171.49 | $50.49 |
| availability | in stock | out of stock |
Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.
What is GLOW and what is PT-141?
GLOW is classified as Co-formulated three-peptide research blend; PT-141 as Synthetic cyclic heptapeptide melanocortin agonist. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.
GLOW
Co-formulated three-peptide research blend
GLOW is a co-formulated research blend that combines three well-characterized reference peptides — GHK-Cu, BPC-157, and TB-500 — in a single vial. Each component is independently established in the literature: GHK-Cu as a copper-binding tripeptide, BPC-157 as a synthetic pentadecapeptide, and TB-500 as a fragment of the actin-binding protein thymosin beta-4.
full GLOW profile →PT-141
Synthetic cyclic heptapeptide melanocortin agonist
PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide analog of the melanocortin family, structurally related to alpha-melanocyte-stimulating hormone and to the earlier research analog Melanotan II. Verve supplies it as a high-purity research compound for laboratory melanocortin-receptor research.
full PT-141 profile →Which research models is each compound studied in?
GLOW and PT-141 both sit inside skin & glow research, so their listed models share framing while differing in specifics. The table lists 5 reported research applications for GLOW and 5 for PT-141. Rows are per compound, not equivalences.
| GLOW — reported research applications | PT-141 — reported research applications |
|---|---|
| Dermal and collagen research models | Melanocortin-receptor (MC1R/MC3R/MC4R) binding research |
| Extracellular-matrix remodeling research | cAMP and G-protein-coupled receptor signaling assays |
| Cell-migration and cytoskeletal research | Receptor-selectivity and structure–activity profiling |
| Multi-compound and combination peptide research | MC1R and melanogenesis research models in cell culture |
| Comparative studies against single-peptide reference controls | Cyclic-peptide stability and conformation research |
Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.
What sizes and prices does verve list for GLOW and PT-141?
GLOW is listed from $171.49 and PT-141 from $50.49. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.
| compound | size listed | price | availability |
|---|---|---|---|
| GLOW | 70mg | $171.49 | in stock |
| PT-141 | 10mg | $50.49 | out of stock |
Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.
shop the compounds →Frequently asked questions about GLOW and PT-141
What is GLOW?
GLOW is a research blend of three peptides — GHK-Cu, BPC-157, and TB-500 — co-formulated in one vial. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is GLOW studied for in research?
It is used in multi-compound dermal, extracellular-matrix remodeling, and cell-migration research models where these three peptides are studied together. Verve makes no health claims.
What is PT-141?
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide melanocortin analog structurally related to alpha-MSH. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is PT-141 studied for in research?
It is used as a reference agonist in melanocortin-receptor research, including MC1R, MC3R, and MC4R binding studies, cAMP signaling assays, and receptor-selectivity profiling. Verve makes no health claims.
related comparisons
verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.